TCON — TRACON Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $0.15m
- -$6.12m
- $12.05m
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Tracon Pharma - Cash & Cash Equivalents Were $13.6 Million At June 30, 2022, Compared To $24.1 Million At December 31, 2021 & Expected To Fund Co Into 2023
Brief: Tracon Pharmaceuticals Announces Results Of Independent Data Monitoring Committee Review Of Safety Data From Envasarc Pivotal Trial
Tracon Pharmaceuticals Inc Expected To Post A Loss Of 37 Cents A Share: Earnings Preview
Tracon Pharma rises after clinical trial application for cancer drug
Brief: Tracon Pharmaceuticals Announces Submission Of Ind Application For Ctla-4 Antibody Yh001 For The Treatment Of Front-Line Sarcoma Patients In Combination With Envafolimab
Brief: Tracon Pharmaceuticals Announces Dosing Of 36th Patient In Envasarc Pivotal Trial Triggering Initial IDMC Efficacy Review Expected In Fourth Quarter
Brief: Tracon Pharmaceuticals Entered Into Purchase Agreement With Opaleye L.P.
Brief: TRACON Pharmaceuticals Inc Says On June 2 ICC Informed Co Of Extended Time Limit For Tribunal To Render Final Decision In Ongoing Arbitration With I-Mab Until Sept 30
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Brief: TRACON Expects Current Cash And Cash Equivalents Will Fund Operations Into 2023
Tracon Pharmaceuticals Inc Expected To Post A Loss Of 42 Cents A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of 42 Cents A Share: Earnings Preview
Brief: Tracon Announces Amended Envasarc Protocol Approved, Open At 30 Clinical Sites
Brief: TRACON Pharmaceuticals Inc Files For Mixed Shelf Of Up To $150 Mln
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In December: Earnings Summary
Brief: Tracon Pharmaceuticals Posts Qtrly Loss Per Share $0.40
Tracon Pharmaceuticals Inc Expected To Post A Loss Of 35 Cents A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Announces FDA Approval Of Amended Envasarc Protocol